Pretreatment neutrophil-to-lymphocyte ratio as an independent predictor of recurrence in patients with nonmetastatic renal cell carcinoma

The Journal of Urology
Yoshio OhnoMasaaki Tachibana

Abstract

We investigated the prognostic significance of the neutrophil-to-lymphocyte ratio to predict recurrence in patients with nonmetastatic renal cell carcinoma. We retrospectively reviewed the records of 192 patients with nonmetastatic renal cell carcinoma (T1-4N0M0) who underwent nephrectomy between 1986 and 2000. Mean followup was 93 months (range 6 to 232) months. We assessed the prognostic value of the pretreatment neutrophil-to-lymphocyte ratio, and other clinical and laboratory parameters on univariate and multivariate analysis. Presentation mode, tumor stage, C-reactive protein, lymphocyte count and the neutrophil-to-lymphocyte ratio significantly correlated with recurrence-free survival on univariate analysis. The recurrence-free survival rate in patients with a neutrophil-to-lymphocyte ratio of less than 2.7 was 93.7% at 5 years and 79.8% at 10 years, significantly higher than the 77.9% and 58.4%, respectively, in patients with a ratio of 2.7 or greater (p = 0.0205). Multivariate analysis revealed that T stage and the neutrophil-to-lymphocyte ratio were independent predictors of recurrence. The 10-year survival rate in patients at low risk (T2 or less and neutrophil-to-lymphocyte ratio less than 2.7), intermediate risk (T2...Continue Reading

References

Aug 6, 1998·Journal of Cancer Research and Clinical Oncology·M HirashimaH Okada
Jul 4, 2001·The Journal of Urology·M W KattanP Russo
Nov 28, 2002·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Amnon ZismanArie S Belldegrun
Jan 30, 2003·The British Journal of Surgery·D C McMillanC S McArdle
Feb 6, 2003·British Journal of Cancer·J AtzpodienUNKNOWN DGCIN -- German Cooperative Renal Carcinoma Chemo-Immunotherapy Trials Group
Dec 19, 2003·The Urologic Clinics of North America·Nicolette K JanzenArie S Belldegrun
Feb 21, 2004·CA: a Cancer Journal for Clinicians·Ahmedin JemalUNKNOWN American Cancer Society
Aug 25, 2005·Journal of Surgical Oncology·S R WalshN J Keeling
Oct 19, 2006·Seminars in Oncology·Brian M ShuchRobert A Figlin
Apr 11, 2008·Breast Cancer Research and Treatment·Brandon L PierceCornelia M Ulrich
May 9, 2008·International Journal of Cancer. Journal International Du Cancer·Jean-Jacques PatardAllan J Pantuck
Jul 25, 2008·Nature·Alberto MantovaniFrances Balkwill
Feb 3, 2009·The Journal of Thoracic and Cardiovascular Surgery·Khaled M SarrafEric Lim

❮ Previous
Next ❯

Citations

Aug 3, 2012·Clinical & Translational Oncology : Official Publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico·S CedrésE Felip
Mar 20, 2014·PloS One·Yong WeiWen-Hui Qian
May 31, 2014·Journal of the National Cancer Institute·Arnoud J TempletonEitan Amir
Oct 4, 2014·Journal of Clinical Laboratory Analysis·Jian LiChaohui Duan
Jun 5, 2014·Cancer Microenvironment : Official Journal of the International Cancer Microenvironment Society·Ronit Vogt SionovZvi Granot
Oct 9, 2012·The Journal of Urology·Sunil SarohaTahseen Al-Saleem
Mar 27, 2012·Urology·Joshua Sleeper, Vitaly Margulis
Dec 20, 2011·The Journal of Urology·Yoshio OhnoMasaaki Tachibana
Jan 19, 2016·Clinical Genitourinary Cancer·Madhur NayanAntonio Finelli
Apr 15, 2015·Asia-Pacific Journal of Clinical Oncology·Seyda GunduzHakan Bozcuk
Sep 22, 2012·Journal of Surgical Oncology·Chien-Liang LiuShih-Ping Cheng
Oct 12, 2013·International Journal of Cancer. Journal International Du Cancer·Matteo SantoniStefano Cascinu
Mar 30, 2016·International Journal of Urology : Official Journal of the Japanese Urological Association·Cheryn SongIll Young Seo
Apr 8, 2016·World Journal of Urology·Boyd R ViersMatthew K Tollefson
Jul 15, 2015·Future Oncology·Matteo SantoniStefano Cascinu
Dec 8, 2014·Seminars in Radiation Oncology·Ralph E Vatner, Silvia C Formenti
Jul 17, 2014·Urologic Oncology·Reza MehrazinTahseen Al-Saleem
Jul 6, 2014·Tumour Biology : the Journal of the International Society for Oncodevelopmental Biology and Medicine·Young Wha KohGyungyub Gong
Aug 22, 2015·BMC Cancer·Houda BahigDenis Soulieres
Apr 4, 2014·Tumour Biology : the Journal of the International Society for Oncodevelopmental Biology and Medicine·Mehmet KaynarErsin Çimentepe

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.